1-2 of 2
Vito Michele Lauta, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m 2 (Mel200) Versus Melphalan 100 mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients.

Antonio Palumbo, MD, Sara Bringhen, MD, Maria Teresa Petrucci, MD, Antonietta Falcone, MD, Anna Marina Liberati, MD, Vito Michele Lauta, MD, Mariella Grasso, MD, Marco Montanaro, MD, Francesco Pisani, MD, Tommaso Caravita, MD, Clotilde Cangialosi, MD, Patrizia Pregno, MD, Andrea Nozza, MD, Elisabetta Calabrese, MD, Francesca Gay, MD, Federica Cavallo, MD, Paola Omedè, BSc, Pellegrino Musto, MD, Robin Foà, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 727.
https://doi.org/10.1182/blood.V110.11.727.727
Published: 2007
Journal Articles

A Prospective Randomized Trial of Oral Melphalan, Prednisone, Thalidomide (MPT) vs Oral Melphalan, Prednisone (MP): An Interim Analysis.

Antonio Palumbo, MD, Alessandra Bertola, MD, Pellegrino Musto, MD, Tommaso Caravita, MD, Vincenzo Callea, MD, Clotilde Cangialosi, MD, Anna Marina Liberati, MD, Pasquale Niscola, MD, Lucio Catalano, MD, Mariella Grasso, MD, Vito Michele Lauta, MD, Maria Concetta Petti, MD, Sergio Morandi, MD, Monica Galli, MD, Sara Bringhen, MD, Federica Cavallo, MD, Patrizia Falco, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2004) 104 (11): 207.
https://doi.org/10.1182/blood.V104.11.207.207
Published: 2004